Braxia Scientific Corp.
BRAX
CNSX
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -7.13M | -8.06M | -9.65M | -9.82M | -9.53M |
| Total Depreciation and Amortization | 270.60K | 356.20K | 441.30K | 424.20K | 309.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.10M | 3.95M | 4.65M | 4.82M | 5.01M |
| Change in Net Operating Assets | 850.00K | -475.70K | -927.70K | -966.50K | -1.36M |
| Cash from Operations | -1.91M | -4.24M | -5.49M | -5.54M | -5.58M |
| Capital Expenditure | -46.20K | -74.60K | -431.30K | -635.70K | -601.80K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 0.00 | 0.00 | 1.40K | 1.40K | 1.40K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 34.70K | 108.40K | -144.80K | -238.30K | -507.60K |
| Cash from Investing | -11.40K | 33.80K | -574.70K | -872.60K | -1.11M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -73.60K | -37.40K | -35.80K | -27.90K | -21.00K |
| Issuance of Common Stock | 1.26M | 1.26M | 1.26M | 1.26M | 2.64M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 880.40K | 907.00K | 908.10K | 913.80K | 2.07M |
| Foreign Exchange rate Adjustments | 32.80K | -1.90K | 53.20K | 58.00K | 20.80K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.01M | -3.30M | -5.10M | -5.44M | -4.59M |
